Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
68 participants
OBSERVATIONAL
2021-02-03
2023-05-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DCE-MRI and DWI for Detection and Diagnosis of Breast Cancer
NCT02022579
Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants
NCT00474604
Abbreviated Breast MRI After Cancer Treatment
NCT03664778
Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection
NCT02411760
Multiple B-value Diffusion-weighted Imaging(DWI) in Evaluation of Breast Lesions
NCT02529384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with breast lesions
Women with an identified breast lesion have a non-invasive non-contrast MRI scan prior to biopsy.
Evaluation of BIT-Motion software
Software program to discern benign versus malignant breast lesions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evaluation of BIT-Motion software
Software program to discern benign versus malignant breast lesions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled for ultrasound or stereotactic guided breast biopsy
* \> 18 years of age
* able to tolerate up to 90 minutes in the MRI scanner
Exclusion Criteria
* Has a medical condition that, in the opinion of the investigator, puts the subject at significant risk
* Has any contraindication to the MRI examination as determined by standard NorthShore University Health System relative to MRI safety
* Cannot comprehend or complete the Informed Consent Form
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Endeavor Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jacob Ecanow
M.D., FPA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacob S Ecanow, MD
Role: PRINCIPAL_INVESTIGATOR
Endeavor Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NorthShore University Health System
Evanston, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EH20-251
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.